Chapter 575 (1/2)
”Yes, boss, and I have a new idea. Boss, you can ask Biyi group to increase the proportion of investment in biopharmaceutical research, and let them invest more angel investment funds to invest in biological R & D teams and individuals who have ideas but have no funds to carry out laboratory specific experiments, and let them do their own research!
No matter whether they can work out any achievements, we are more happy to have the results, we can continue to increase investment, and there is no need to be disappointed if there are no concrete results.
Because even if their research is wrong, or there is no profit from the results, their research data and R & D process is not a small gain, at least it can let our company's headquarters take a lot of detours and save more R & D time!
I think with the development speed of Biyi group and the support of your boss, it is very easy for them to invest 5 billion US dollars in the field of biopharmaceuticals every year.
And our company can also let our angel investment department make angel investment in the field of biopharmaceuticals. The funds here are more abundant, and there is no problem to invest $10 billion every year!
With more than 15 billion US dollars invested each year, we can basically make global investment in many biopharmaceutical fields!
These investments can bring huge R & D data to the company. After these data are integrated by the company, the company's R & D database can become very substantial, so that the company has more data support for related R & D!
We can also use our own private funds to invest in related fields. The day-to-day investment management company I am in charge of can be responsible for the investment work in this respect. With our current capital scale, it is also a matter of pouring water into another 15 billion US dollars of investment!
This fund can be invested in those companies and countries that are hostile to us. With a little money, they can help us carry out research and development in the field of biopharmaceuticals. I'm glad to think about it!
In this way, we will invest more than 30 billion US dollars in angel investment every year, which will greatly promote the R & D process in the field of biopharmaceuticals!
After all, the amount of our investment is more than the total annual investment in the field of biopharmaceuticals in the world. It would be strange if such a large amount of investment could not promote the R & D process in related fields!
After all, our investment is not a completely profit seeking investment. There is little way to obtain angel investment for some biological R & D work without profit. However, the research abandoned by capital is also very valuable for us!
For example, boss, you know that the hot spot of investment in the field of biopharmaceuticals is in the research of new drugs related to anticancer drugs. Few pharmaceutical companies conduct research on the research and development of some minor diseases. Even if there are, large companies will only do it after receiving state subsidies, and the drugs developed are all sky high price drugs!